Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy
Clinical trial NCT02464228 · COMPLETED
Trial details
- NCT number
- NCT02464228
- Sponsor
- Kura Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-25
- Primary completion
- 2021-03-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.